Bold opportunities to change the course of mental health care.

SEC Filing

Form

Filing Date

May 26, 2011

Document Date

May 26, 2011

Form Description

Statement regarding change in majority of directors pursuant to Rule 14f-1

Filing Group

Other

Company

Vistagen Therapeutics, Inc

Issuer

VistaGen Therapeutics, Inc.

View HTML

Annual Reports

Annual reports provide a comprehensive overview of the company for the past year

View Reports

Quarterly Reports

Quarterly reports provide a continuing view of the company's financial position

View Reports

SEC Filings

Statement of changes in beneficial ownership of securities

View Filings